|
"kao j h"的相關文件
顯示項目 1181-1190 / 1534 (共154頁)
<< < 114 115 116 117 118 119 120 121 122 123 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2019 |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.;Yang H.-C.;Tseng T.-C.;Chou S.-W.;Chin-Hsien Lin;Liu C.-H.;Liu C.-J.;Chen C.-L.;Kao J.-H.; Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; CHIN-HSIEN LIN; Liu C.-H.; Liu C.-J.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2019 |
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
|
Hsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2019 |
Successful treatment of nasal-type extra-nodal natural killer/T cell lymphoma with simultaneous involvement of the thyroid, liver, and pancreas
|
Chang S.-H.; Kao J.-H.; Liang J.-D.; SHANG-JU WU |
| 臺大學術典藏 |
2019 |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
Kao J.-H.; Chen C.-L.; Chen D.-S.; Chen P.-J.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; SHANG-JU WU |
| 國立成功大學 |
2019 |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu, C.-H.;Shih, Y.-L.;Yang, S.-S.;Lin, C.-L.;Fang, Y.-J.;Cheng, P.-N.;Chen, Chen C.-Y.;Peng, C.-Y.;Hsieh, T.-Y.;Chiu, Y.-C.;Su, T.-H.;Liu, C.-J.;Yang, H.-C.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H. |
| 國立成功大學 |
2019 |
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study
|
Liu, C.-H.;Yu, M.-L.;Peng, C.-Y.;Hsieh, T.-Y.;Huang, Y.-H.;Su, W.-W.;Cheng, P.-N.;Lin, C.-L.;Lo, C.-C.;Chen, Chen C.-Y.;Chen, J.-J.;Ma, Q.;Brooks-Rooney, C.;Kao, J.-H. |
| 國立成功大學 |
2019 |
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
|
Yu, M.-L.;Hung, C.-H.;Huang, Y.-H.;Peng, C.-Y.;Lin, C.-Y.;Cheng, P.-N.;Chien, R.-N.;Hsu, S.-J.;Liu, C.-H.;Huang, C.-F.;Su, C.-W.;Huang, J.-F.;Liu, C.-J.;Kao, J.-H.;Chuang, W.-L.;Chen, P.-J.;Chen, D.-S. |
| 臺大學術典藏 |
2018-09-10T18:07:03Z |
Prevention of mother-to-child transmission: the key of hepatitis B virus elimination
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Preface
|
Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy
|
Su, T.-H.;Yang, H.-C.;Tseng, T.-C.;Liou, J.-M.;Liu, C.-H.;Chen, C.-L.;Chen, P.-J.;Chen, D.-S.;Liu, C.-J.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; JIA-HORNG KAO |
顯示項目 1181-1190 / 1534 (共154頁)
<< < 114 115 116 117 118 119 120 121 122 123 > >>
每頁顯示[10|25|50]項目
|
